|
Volumn 84, Issue 4, 2000, Pages 438-439
|
Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline [1]
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR;
CYTOKINE;
FAS ANTIGEN;
PENTOXIFYLLINE;
PLACEBO;
TUMOR NECROSIS FACTOR ALPHA;
APOPTOSIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONGESTIVE CARDIOMYOPATHY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION FUNCTION;
CYTOKINE PRODUCTION;
DOUBLE BLIND PROCEDURE;
HEART LEFT VENTRICLE EJECTION FRACTION;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE CELL;
HUMAN;
LETTER;
PATHOGENESIS;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
ANTIGENS, CD95;
APOPTOSIS;
BIOLOGICAL MARKERS;
CARDIOMYOPATHY, DILATED;
CASE-CONTROL STUDIES;
DOUBLE-BLIND METHOD;
HUMANS;
MIDDLE AGED;
PENTOXIFYLLINE;
PHOSPHODIESTERASE INHIBITORS;
PROSPECTIVE STUDIES;
TUMOR NECROSIS FACTOR-ALPHA;
VENTRICULAR DYSFUNCTION, LEFT;
|
EID: 0033808449
PISSN: 13556037
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (33)
|
References (0)
|